Home › Cholesterol › Virginia › Alexandria
Cholesterol clinical trials in Alexandria, VA
3 studies for Cholesterol are looking for participants at sites in and around Alexandria (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- MedStar Southern Maryland Hospital Center, Clinton · 8 mi away
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
RecruitingPhase 3
- Research Site, Oxon Hill · 3 mi away
A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
RecruitingPhase 2
- Anderson Medical Research, Ft. Washington · 7 mi away
About Cholesterol
Your body needs some cholesterol, but too much can raise your risk of heart disease. Know the types (HDL and LDL), and how to lower high cholesterol.
More about Cholesterol on MedlinePlus
Cholesterol trials in other cities
- Washington, DC6 studies
- Hialeah, FL5 studies
- Durham, NC4 studies
- Clearwater, FL4 studies
- Deltona, FL4 studies
- Jacksonville, FL4 studies
- Richmond, VA4 studies
- Dallas, TX3 studies
- Winston-Salem, NC3 studies
- New York City, NY3 studies
- Salt Lake City, UT3 studies
- St. Louis, MO3 studies
Other studies in Alexandria
- Non-Small Cell Lung Cancer11 studies
- Lung Cancer7 studies
- Breast Cancer6 studies
- Atherosclerosis5 studies
- Cardiovascular Disease5 studies
- Type 2 Diabetes5 studies
- High Blood Pressure4 studies
- Obesity4 studies
- Colon Cancer4 studies
- Overweight3 studies
- Colorectal Cancer3 studies
- Stroke3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.